Didier Blaise, MD, PhD, Paoli-Calmettes Institute, Marseille, France, comments on the importance of selection in stem cell transplantation (SCT) for elderly patients with acute myeloid leukemia (AML). Dr Blaise expresses the importance of geriatric assessments to ensure patients can tolerate the procedure and to plan for supportive care to improve post-transplant outcomes. This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
